High Homocysteine Only Means Something Next to B12, Folate, and MMA

High homocysteine with normal B12 and folate means you are not looking at a simple dietary B12 or folate deficiency, at least not by serum numbers. It can mean a functional B12 deficiency that only shows up as high methylmalonic acid, reduced MTHFR enzyme activity, slower homocysteine clearance through the kidney, or a rarer inborn remethylation defect. Homocysteine is a signal to read next to other markers, not a diagnosis in isolation.

A high homocysteine value only becomes useful next to B12, folate, and methylmalonic acid.

What does high homocysteine mean with normal B12 and folate?

Someone typing this usually has lab results in front of them: total homocysteine above the reference interval, serum B12 and folate sitting inside their intervals. The mistake is to read that as "B12 and folate are fine, so this must be MTHFR." Serum B12 can look normal while tissue B12 is not. Serum folate can look normal while the active methylfolate supply is limited, or while MTHFR function slows the conversion. Homocysteine rises when remethylation is blocked, whatever the reason.

What you actually want is the pattern across three moving parts:

• Total homocysteine: high, but alone it does not say why.
• Methylmalonic acid (MMA): high MMA points to B12, because B12 is needed to clear MMA.
• B12 and folate: normal serum levels do not rule out a functional B12 problem.

If MMA is high with high homocysteine, the B12 side is struggling even if serum B12 reads normal. If MMA is normal with high homocysteine, look at folate, MTHFR, B6/CBS transsulfuration, and rarer remethylation defects. Kidney disease can also raise MMA, so a normal MMA does not rule out kidney involvement.

Check MMA before you chase MTHFR

MMA is the marker that keeps an MTHFR result honest. High MMA with high homocysteine points to combined cobalamin defects such as cobalamin C, where the B12 cofactor is missing from two reactions, methylmalonyl-CoA mutase and methionine synthase. Cobalamin E and G remethylation defects can show high homocysteine with normal MMA, because they impair methionine synthase but not methylmalonyl-CoA mutase. In MTHFR deficiency, homocysteine is high but MMA is not the main problem. That distinction matters. A person with high homocysteine and high MMA should not be treated as a standalone MTHFR case. They have a B12 side issue until shown otherwise.

The common mistake is to see high homocysteine, then scroll through a raw DNA report, find MTHFR C677T, and stop. MTHFR variants change the enzyme's efficiency in some people, but the enzyme works inside a system that includes riboflavin, B12, folate, choline, betaine, and kidney clearance. A genotype tells you about one enzyme, not about the whole system.

What a useful lab panel looks like

If you are going to track this, ask for the markers that move together:

• Total homocysteine.
• Serum B12.
• Serum or red cell folate.
• Methylmalonic acid, serum or urine.

The exact reference intervals vary by lab. The pattern across those markers matters more than any single result. This is why an isolated homocysteine value, or an isolated MTHFR genotype, is not enough.

Why homocysteine needs B12, folate, and MTHFR to move

Homocysteine sits at a branch point. It can be remethylated back to methionine using N5-methyltetrahydrofolate as the methyl donor and B12 as the cofactor. MTHFR makes that active folate form. It can also be converted to cysteine through a B6-dependent pathway. When remethylation slows, homocysteine accumulates.

If B12 is low or not working, methylfolate gets trapped and MMA also accumulates. If folate or MTHFR is the bottleneck, MMA stays normal. That is why high homocysteine alone cannot tell you which bottleneck you have.

What the rare remethylation disorders actually look like

The E-HOD registry data shows these disorders are usually not subtle adult findings. The registry followed 238 patients from 47 centres. The most common was cobalamin C defect at 161 patients, then MTHFR deficiency at 50, with cobalamin G, E, D, and J making up the rest.

Among 181 clinically diagnosed patients, the median age at presentation was 30 days, with a range from 1 day to 42 years. The median age at diagnosis was 3.7 months, ranging from 3 days to 56 years. Among pre-clinically diagnosed cobalamin C patients, 75% became symptomatic within the first 15 days of life. Neurological disease, eye disease, and failure to thrive dominated the clinical picture. Early treatment correlated with lower overall morbidity, but neurocognitive and eye symptoms were less responsive. That is the honest limit of treatment, even when it starts early.

The obvious follow-up: methylfolate is not a fix by default

Not necessarily. If methylmalonic acid is high, methylfolate is not the direct solution. In functional B12 deficiency, folate can partially lower homocysteine while the B12 problem continues. In the E-HOD registry, treatment was highly variable across centres; approaches included B12, betaine, and folate or folinic acid, so there is no single methylfolate protocol for remethylation disorders.

The practical question to ask is not "which supplement should I take?" It is "what is my homocysteine doing next to B12, folate, and MMA?" If those markers have not been measured, an isolated homocysteine or MTHFR result is unfinished.

When the simple answer does not hold

A few situations make high homocysteine with normal B12 and folate messier. Reduced kidney clearance can raise homocysteine without a remethylation enzyme problem, but kidney disease can also raise MMA. Nitrous oxide exposure mainly inactivates methionine synthase, so it typically raises homocysteine without raising MMA. Hypothyroidism, some medicines, and recent illness can shift homocysteine. Rare inborn errors can present later, but the E-HOD registry shows they usually present early and hit hard.

The reverse also happens. Someone can have a homozygous MTHFR C677T result and normal homocysteine. In that case the variant is not creating a measurable homocysteine problem under current conditions.